TILT Holdings Inc. (“TILT” or the “Company”) (CSE:TILT, OTCMKTS:SVVTF), a vertically-integrated infrastructure and technology cannabis company, announced today the appointment of Dr. San Li as Senior Lab Director for its wholly-owned subsidiary Jupiter Research (“Jupiter”), a leading designer, developer and manufacturer of vaporizing technologies for natural plant-derived oil.

Dr. Li has decades of experience working in various research and product development organizations at Altria and Philip Morris USA. His expertise includes innovative product development, e-Vapor product development, cigarette development, flavor development, innovation and applied technology, and smoke constituent reduction. He also focuses on research into new technology, sensory, smoke and analytical research. Dr. Li holds more than 20 U.S. patent issues on new inhalation products and technologies.


Jupiter Research is a leader in the global vaping market, which – along with e-cigarettes – was valued at $10.26 billion in 2018 and is expected to grow at a CAGR of 24.9% from 2019 to 2025, according to a new study by Grand View Research, Inc. Dr. Li’s experience will help Jupiter Research increase the Company’s current market share and further expand its reach in the rapidly growing industry. Jupiter Research produces specifically-designed cartridges and power supplies for cannabis oil, featuring exclusively ceramic CCELL technology. Jupiter’s team is focused on the vast potential of inhalation products and partners with more than 800 brands, as well as cannabis retailers across 33 states in the United States, as well as in Canada, Israel, Mexico, South America and the European Union.

“We are thrilled to have Dr. San Li leading our research and development as Senior Lab Director of Jupiter Research,” said Mark Scatterday, interim CEO of TILT Holdings, Inc. “Dr. Li is an expert on developing new products, innovating technology, e-Vapor products and flavor delivery systems. He will bring strategic thinking and multi-disciplinary knowledge that can help solve complex technical challenges, improve sensory performance, and expand the breadth of cannabis vape and inhalation products for Jupiter Research.”

As Senior Lab Director, Dr. Li will develop new products and technologies to improve inhalation experience, safety and efficacy of cannabinoids and terpenes. Dr. Li will build out Jupiter’s research and technical capabilities to support current and future products. He will apply his experience with tobacco product development to evaluate new concepts and technologies to improve product safety profiles.

“I am honored to be appointed Senior Lab Director of Jupiter Research and look forward to working closely with the entire team on expanding Jupiter’s proprietary inhalation technology offerings,” said Dr. San Li. “With more than 20 years of experience in product development and innovation, I am passionate about the work that Jupiter Research is doing and look forward to helping them grow their vision of new product concepts and technologies.”

To learn more about TILT Holdings, Inc. visit www.tiltholdings.com. For more information about Jupiter Research, visit www.jupiterresearch.com.

About TILT

TILT is a leading provider of products and services to businesses operating in the cannabis industry. The Company offers the contract manufacturing of marijuana in a variety of form factors, vaporizer and inhalation devices, business and consumer delivery services and a broad suite of software products for over 1,500 retailers and brands throughout the United States (“U.S.”), Canada and Europe. The majority of TILT’s products are customized to client specifications and branding, all enabling them to operate their businesses more efficiently and connect with their customers more effectively. The Company is organized in three main business units, Cultivation & Production, Software & Services and Consumer Devices & Packaged Goods, designed to augment competencies across the organization in research, manufacturing, packaging and technology to deliver end-to-end services and customer solutions. All of TILT’s products are supported by an extensive research process led by scientists and engineers, using data analytics and discovery to produce new products helping shape the industry. Headquartered in Cambridge, MA, with offices throughout the U.S., Toronto and London, TILT has over 500 employees and has sales in 40 U.S. states, Canada and Europe. For more information, please visitwww.tiltholdings.com.

Click here to connect with TILT Holdings (CSE: TILT, OTCQB: SVVTF) for an Investor Presentation

Source: www.businesswire.com

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less